12-08-2025, 18:00

AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

Notified -
Globe Newswire12-08-2025, 18:00
28-04-2025, 18:00

AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer

Notified -
Globe Newswire28-04-2025, 18:00